Research graph
References from Chinese herbal compounds against SARS-CoV-2: Puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/s0140-6736(20)30183-5
10.1016/s0140-6736(20)30183-5 · External reference
10.7861/clinmed.2019-coron
10.7861/clinmed.2019-coron · External reference
10.1007/s11427-020-1637-5
10.1007/s11427-020-1637-5 · External reference
10.1128/jvi.06882-11
10.1128/jvi.06882-11 · External reference
10.1038/nature02145
10.1038/nature02145 · External reference
10.1038/nature12005
10.1038/nature12005 · External reference
10.1038/s41564-020-0688-y
10.1038/s41564-020-0688-y · External reference
10.1126/science.abb2762
10.1126/science.abb2762 · External reference
10.1038/s41586-020-2180-5
10.1038/s41586-020-2180-5 · External reference
10.1016/j.cell.2020.03.045
10.1016/j.cell.2020.03.045 · External reference
Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS
10.1002/ptr.1485 · 2004 · External reference
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
10.1136/bmj.m606 · 2020 · External reference
Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae
2010 · External reference
10.3724/sp.j.1009.2013.00110
10.3724/sp.j.1009.2013.00110 · External reference
10.1155/2013/731969
10.1155/2013/731969 · External reference
Uncovering the action mechanism of polydatin via network pharmacological target prediction
10.1039/c8ra03124j · 2018 · External reference
Unraveling the action mechanism of polygonum cuspidatum by a network pharmacology approach
2019 · External reference
Unresolved reference
2004 · External reference
Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
10.1016/j.phrs.2020.104761 · 2020 · External reference
Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: a multicenter, prospective, randomized controlled trial
2020 · External reference
Potential natural compounds for preventing SARS-CoV-2 (2019-nCoV) infection
2020 · External reference
Radix Bupleuri: a review of traditional uses, botany, phytochemistry, pharmacology, and toxicology
2017 · External reference
A systematic review of the active saikosaponins and extracts isolated from Radix Bupleuri and their applications
10.1080/13880209.2016.1262433 · 2017 · External reference
Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species
10.1055/s-2003-42797 · 2003 · External reference
10.3109/08923973.2010.527985
10.3109/08923973.2010.527985 · External reference
A novel nasal delivery system of a chinese traditional medicine,Radix Bupleuri, based on the concept of ion-activated in situ gel
10.1007/bf02993971 · 2007 · External reference
10.1016/j.joim.2020.02.005
10.1016/j.joim.2020.02.005 · External reference
10.1038/s41422-020-0282-0
10.1038/s41422-020-0282-0 · External reference
Puerarin: a review of pharmacological effects: activity of puerarin
10.1002/ptr.5083 · 2014 · External reference
Progress on the pharmacological research of puerarin: a review
10.1016/s1875-5364(14)60064-9 · 2014 · External reference
Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov
2020 · External reference
